| Name | cefamandole nafate |
|---|---|
| Synonyms |
Cefamandole (nafate)
Cefamandole nafate,Cefamandole formate sodium salt Mandokef Fado Neocefal Cefam cephamandole nafate EINECS 255-877-4 Cefamandole Nafate sterila O-Formylcefamandole sodium Nafate Cedol Cemandil sodium (6R,7R)-7-[(2R)-2-(formyloxy)-2-phenylacetamido]- 3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]met hyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-ca rboxylate (6R-(6a,7b(R*)))-7-(((Formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Monosodium Sal 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt, (6R,7R)- (1:1) Mandol mandol Kefandol Cefaseptolo Sodium O-formylcefamandole UNII-8HDO7941DO 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylicacid,7-[[(2R)-2-(forMyloxy)-2-phenylacetyl]amino]-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-,sodiuM salt (1:1), (6R,7R) (6r-(6-alpha,7-beta(r))) Cefamandole formate sodium salt Cefamandole nafate Sodium Cefamandole Nafate (DISCONTINUED) CeMandil cefamandolnafato chamandolenafate Sodium (6R,7R)-7-(R)-mandelamido-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylate formate (ester) 7-[(2-formyloxy-1-oxo-2-phenylethyl)amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylic acid Sodium [6R-[6alpha,7beta(R*)]]-7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylate Cemandil sodium salt //BP CeMado 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-cboxylicacid,7-(((formyloxy)phenylace LaMpoMandol sodium:(6R,7R)-7-[(2-formyloxy-2-phenylacetyl)amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylate Cefiran (6R,7R)-7-[[(2R)-2-(ForMyloxy)-2-phenylacetyl]amino]-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylic Acid SodiuM Salt sodium [6R-[6α,7β(R*)]]-7-[[(formyloxy)phenylacetyl]amino] Cefamandole Nafate o-formylcefamandolesodium Bergacef Pavecef Cefamandole nafate CRS CefamandoleNafate Cefamandole formate sodium Cefamandole Nafate API CefaMandole ForMate SodiuM Cemandil Sodium Cemandil sodium salt CefaM CEFAMANDOLE FORMATE SODIUM SALT Mandolsan Sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Cefamandole Nafate -Delta-3- Isomer Kefadol sodium [6R-[6α,7β(R*)]]-7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylate MFCD00864877 |
| Description | Cefamandole nafate is a second-generation broad-spectrum cephalosporin antibiotic. |
|---|---|
| Related Catalog |
| Melting Point | 190-193ºC |
|---|---|
| Molecular Formula | C19H17N6NaO6S2 |
| Molecular Weight | 512.495 |
| Exact Mass | 512.054871 |
| PSA | 210.04000 |
| Storage condition | -20?C Freezer, Under Inert Atmosphere |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H315-H317-H319-H334-H335 |
| Precautionary Statements | P261-P280-P284-P304 + P340-P305 + P351 + P338-P342 + P311 |
| Hazard Codes | Xn |
| Risk Phrases | 36/37/38-42/43 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | XI0380000 |
| HS Code | 3003201900 |
|
~%
42540-40-9 |
| Literature: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MOODY, Harold, Monro; MAAS, Peter, Johannes, Dominicus; SCHMITGES, Thomas Patent: WO2013/57197 A1, 2013 ; Location in patent: Page/Page column 11 ; |
|
~%
42540-40-9 |
| Literature: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MOODY, Harold, Monro; MAAS, Peter, Johannes, Dominicus; SCHMITGES, Thomas Patent: WO2013/57197 A1, 2013 ; |
|
~%
42540-40-9 |
| Literature: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MOODY, Harold, Monro; MAAS, Peter, Johannes, Dominicus; SCHMITGES, Thomas Patent: WO2013/57197 A1, 2013 ; |
|
~%
42540-40-9 |
| Literature: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.; MOODY, Harold, Monro; MAAS, Peter, Johannes, Dominicus; SCHMITGES, Thomas Patent: WO2013/57197 A1, 2013 ; |
| Precursor 4 | |
|---|---|
| DownStream 0 | |
| HS Code | 3003201900 |
|---|